Multiple Assemblies exist for SMTL entry 5aaw
Structure of a redesigned cross-reactive antibody to dengue virus with increased in vivo potency; X-RAY DIFFRACTION 3.27 Å

	SMTL ID 5aaw.1 Ligands - Polypeptides SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3 Oligo-state hetero-oligomer
	SMTL ID 5aaw.2 Ligands - Polypeptides SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3 Oligo-state hetero-oligomer
	SMTL ID 5aaw.3 Ligands - Polypeptides SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3 Oligo-state hetero-oligomer
	SMTL ID 5aaw.4 Ligands - Polypeptides SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3 Oligo-state hetero-oligomer
	SMTL ID 5aaw.5 Ligands - Polypeptides SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3 Oligo-state hetero-oligomer
	SMTL ID 5aaw.6 Ligands - Polypeptides SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3 Oligo-state hetero-oligomer